Skip to main content
CHRS logo

CHRS · Coherus Oncology, Inc. · Short Interest

Track CHRS — free
$0.77 +0.02 (+2.82%) At close · Nov 6 Play latest call Q2 2026 earnings call transcript
Market Cap
$118.97M
Shares
154.50M
Volume · Nov 6 1.08M Avg daily vol (3M) 1.45M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

CHRS Latest Reported Short Interest

FINRA reported 12,452,177 CHRS shares sold short as of the October 15, 2026 settlement date, a decrease of 10,885,362 shares. Days to cover was 7.88 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

CHRS Short Interest Forecast

Equibles' model estimates 12,620,645 shares sold short for the October 30, 2026 settlement, +1.4% versus the latest reported position, with a likely range of 10,793,046 to 14,831,144 shares. This model prediction uses FINRA data through October 30, 2026; FINRA's official release is expected November 10, 2026.

Model estimate

Expected Oct 30 short interest

as of Oct 30 High confidence 62% chance it rises
12,620,645 +1.4% vs reported
Likely range 10,793,046 to 14,831,144 The latest estimate appears in the chart below. Official release expected Nov 10. Methodology
Short Squeeze Score
70/100
Short interest 8.1% of shares — P83 Days to cover 7.9 — P83 Price vs VWAP -32.5% — P14 Short-volume trend +2.4% — P61 Short interest change -46.6% — P6 Worst FTD 0.03% of shares — P66 Earnings soon +10

Positioning score 60.1 + catalyst boost 10 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-10-15). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-11-07 19:49 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-11-13 Scheduled
FINRA publishes Nov 24
— — — —
2026-10-30 Scheduled
FINRA publishes Nov 10
— — — —
2026-10-15 12,452,177 23,337,539 -10,885,362 7.88
2026-09-30 23,337,539 22,848,985 +488,554 12.53
2026-09-15 22,848,985 23,915,667 -1,066,682 32.76
2026-08-31 23,915,667 23,997,214 -81,547 16.84
2026-08-14 23,997,214 24,527,052 -529,838 19.71
2026-07-31 24,527,052 23,885,705 +641,347 53.59
2026-07-15 23,885,705 25,975,163 -2,089,458 24.36
2026-06-30 25,975,163 25,637,521 +337,642 21.88
2026-06-15 25,637,521 27,872,603 -2,235,082 33.41
2026-05-29 27,872,603 28,108,039 -235,436 23.66
2026-05-15 28,108,039 27,818,409 +289,630 17.16
2026-04-30 27,818,409 27,972,356 -153,947 25.51
2026-04-15 27,972,356 28,142,006 -169,650 34.70
2026-03-31 28,142,006 28,025,097 +116,909 20.68
2026-03-13 28,025,097 27,657,585 +367,512 17.49
2026-02-27 27,657,585 29,614,243 -1,956,658 20.59
2026-02-13 29,614,243 29,597,546 +16,697 12.22
2026-01-30 29,597,546 29,738,849 -141,303 5.77
2026-01-15 29,738,849 29,066,312 +672,537 18.03
2025-12-31 29,066,312 29,855,093 -788,781 38.11
2025-12-15 29,855,093 29,639,306 +215,787 29.33
2025-11-28 29,639,306 29,176,605 +462,701 28.21
2025-11-14 29,176,605 30,098,437 -921,832 16.77

Full FINRA short interest reporting calendar

Showing 1–23 of 23 settlements
Key facts CIK 1512762 CUSIP 19249H103 13F (30d) 72 filings 49 filers Visit website Investor relations